Effects of rivastigmine on cognitive function in patients with traumatic brain injury

Authors :: Silver, J M.
Koumaras, B
Chen, M
Mirski, D
Potkin, S G.
Reyes, P
Warden, D
Harvey, P D.
Arciniegas, D
Katz, D I.
Gunay, I
Source :: Neurology (Ovid); September 2006, Vol. 67 Issue: 5 p748-755, 8p
Publication Year :: 2006
Abstract: To compare the efficacy and safety of rivastigmine (3 to 6 mg/day) vs placebo over 12 weeks in patients with traumatic brain injury and persistent cognitive impairment.

Full Text Access

Tools